Efficacy of Dual Inhibition of Glycolysis and Glutaminolysis for Therapy of Renal Lesions in Tsc2(+/−) Mice()

por Jones, Ashley T., Narov, Kalin, Yang, Jian, Sampson, Julian R., Shen, Ming Hong
Publicado 2019

mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3

por Dodd, Kayleigh M., Yang, Jian, Shen, Ming Hong, Sampson, Julian R., Tee, Andrew R.
Publicado 2014

The dual PI3K/mTOR inhibitor GSK2126458 is effective for treating solid renal tumours in Tsc2(+/-) mice through suppression of cell proliferation and induction of apoptosis

por Narov, Kalin, Yang, Jian, Samsel, Paulina, Jones, Ashley, Sampson, Julian R, Shen, Ming Hong
Publicado 2017

Assessment of Response of Kidney Tumors to Rapamycin and Atorvastatin in Tsc1(+/−) Mice

por Shen, Ming Hong, Samsel, Paulina, Shen, Louise L., Narov, Kalin, Yang, Jian, Sampson, Julian R.
Publicado 2017

Allosteric and ATP-Competitive Inhibitors of mTOR Effectively Suppress Tumor Progression-Associated Epithelial-Mesenchymal Transition in the Kidneys of Tsc2(+/−) Mice

por Jones, Ashley T., Yang, Jian, Narov, Kalin, Henske, Elizabeth P, Sampson, Julian R., Shen, Ming Hong
Publicado 2019

Clinical value of Cyclin D1 and P21 in the differential diagnosis of papillary thyroid carcinoma

por Wang, Chen-chen, Lu, Dan-dan, Shen, Ming-hong, Chen, Ru-lei, Zhang, Zhi-hong, Lv, Jing-huan
Publicado 2023

Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2(+/−) Mice Is Superior to Everolimus Alone()

por Yang, Jian, Samsel, Paulina A., Narov, Kalin, Jones, Ashley, Gallacher, Daniel, Gallacher, John, Sampson, Julian R., Shen, Ming Hong
Publicado 2017